Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression (GENI)
Primary Purpose
Psychiatric Disorder
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
study of the transmission of genetic variants
Sponsored by
About this trial
This is an interventional other trial for Psychiatric Disorder
Eligibility Criteria
Inclusion Criteria:
- For patients:
- Subjects suffering from (according to DSM IV criteria) : Bipolar disorder, Unipolar depression, Schizophrenia, Autism spectrum disorder
- Age over 18 years
- Subject affiliated to the social security system
- Including patients under guardianship, curatorship,
- Patients included in the Fondation FondaMental cohort whose genetic analyses have revealed the need for comparative and functional genetic studies.
- Having signed the consent form
For relatives :
- Age over 18 years
- Relative of patient included in the Fondattion FondaMental cohort
- Including relative under guardianship, curatorship
- Having signed the consent
- Affiliated to social security
Exclusion Criteria:
- For all subjects:
- Any condition that, in the opinion of the investigator, would make the subject's participation in the study undesirable or that would compromise compliance with the protocol
- Persons deprived of liberty
- Inability to understand French
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Patients
Relatives
Arm Description
Subject suffering from (according to DSM IV criteria) bipolar disorder unipolar depression schizophrenia autism spectrum disorder Collection of hair follicle cells
Relatives of enrolled patients suffering from psychiatric disorder. test to detect psychiatric disorders blood or saliva sampling for genomic DNA extraction Collection of hair follicle cells
Outcomes
Primary Outcome Measures
Measure of the probability of having a psychiatric disorder given the presence of the genetic variant studied.
Test for psychiatric disorders Study of the genetic variant of interest by sequencing or genotyping on genomic DNA.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05480826
Brief Title
Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression
Acronym
GENI
Official Title
Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
March 15, 2023 (Anticipated)
Primary Completion Date
September 15, 2027 (Anticipated)
Study Completion Date
September 15, 2028 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation FondaMental
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Genetic analyses conducted on patient with psychiatric disorders assessed at the expert centres resulted in the identific action of genetic variants associated with psychiatric disorders (Courtois, 2020). These data require further genetic and functional analyses. The first objective of this study is to investigate the disease-related inheritance of genetic variants in the families of individuals in whom these variants have been identified. The second objective is to explore the functional consequences of disease-associated genetic variants in patients cells and those of their relatives with and without these variants.
The present project aims to enrich existing biocollections with DNA from blood or saliva from relatives of patients identified with genetic variants. In addition, we wish to collect hair follicules from patients with identified genetic variants of interest and their family members who wish to participate in the study. These hair samples with SNA will be used to dedifferentiate the isolated cells into induced pluripotent stem cells (IPSCs), and then to differentiate them into cells expressing the gene of interest, such as neurons or astrocytes, or into more complex systems, such as brain organoids.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychiatric Disorder
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2 groups of subjects are enrolled in the study:
patients with a mental disorder
relatives of patients included
Masking
Outcomes Assessor
Allocation
Non-Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Patients
Arm Type
Other
Arm Description
Subject suffering from (according to DSM IV criteria)
bipolar disorder
unipolar depression
schizophrenia
autism spectrum disorder
Collection of hair follicle cells
Arm Title
Relatives
Arm Type
Other
Arm Description
Relatives of enrolled patients suffering from psychiatric disorder.
test to detect psychiatric disorders
blood or saliva sampling for genomic DNA extraction
Collection of hair follicle cells
Intervention Type
Genetic
Intervention Name(s)
study of the transmission of genetic variants
Intervention Description
the genetic variants of interest will be investigated by sequencing or genotyping on genomic DNA
Primary Outcome Measure Information:
Title
Measure of the probability of having a psychiatric disorder given the presence of the genetic variant studied.
Description
Test for psychiatric disorders Study of the genetic variant of interest by sequencing or genotyping on genomic DNA.
Time Frame
through study completion, an average of 5 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
For patients:
Subjects suffering from (according to DSM IV criteria) : Bipolar disorder, Unipolar depression, Schizophrenia, Autism spectrum disorder
Age over 18 years
Subject affiliated to the social security system
Including patients under guardianship, curatorship,
Patients included in the Fondation FondaMental cohort whose genetic analyses have revealed the need for comparative and functional genetic studies.
Having signed the consent form
For relatives :
Age over 18 years
Relative of patient included in the Fondattion FondaMental cohort
Including relative under guardianship, curatorship
Having signed the consent
Affiliated to social security
Exclusion Criteria:
For all subjects:
Any condition that, in the opinion of the investigator, would make the subject's participation in the study undesirable or that would compromise compliance with the protocol
Persons deprived of liberty
Inability to understand French
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Stephane JAMAIN, PhD
Phone
149813775
Ext
+33
Email
stephane.jamain@inserm.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marion Leboyer, MD PhD
Organizational Affiliation
Fondation FondaMental
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Stephane JAMAIN, PhD
Organizational Affiliation
Institut National de la Santé Et de la Recherche Médicale, France
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression
We'll reach out to this number within 24 hrs